共 50 条
- [41] Comment on: “Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines” PharmacoEconomics, 2014, 32 : 1245 - 1246
- [44] The cost-effectiveness of hypertension management in low-income and middle-income countries: a review BMJ GLOBAL HEALTH, 2020, 5 (09):
- [48] Cost of illness of breast cancer in low- and middle-income countries: a systematic review HEALTH ECONOMICS REVIEW, 2024, 14 (01):